Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
US Department of Justice
Queensland Health
Dow
Colorcon
Express Scripts
Daiichi Sankyo
Harvard Business School
Fish and Richardson
Boehringer Ingelheim

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075530

« Back to Dashboard

NDA 075530 describes MILRINONE LACTATE, which is a drug marketed by Baxter Hlthcare Corp, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma Farmaceutica, Hospira, Hospira Inc, Intl Medicated, Mylan Institutional, West-ward Pharms Int, Renaissance Ssa Llc, B Braun, and Baxter Hlthcare, and is included in twenty NDAs. It is available from five suppliers. Additional details are available on the MILRINONE LACTATE profile page.

The generic ingredient in MILRINONE LACTATE is milrinone lactate. There are nine drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the milrinone lactate profile page.
Summary for 075530
Tradename:MILRINONE LACTATE
Applicant:West-ward Pharms Int
Ingredient:milrinone lactate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 075530
Suppliers and Packaging for NDA: 075530
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MILRINONE LACTATE milrinone lactate INJECTABLE;INJECTION 075530 ANDA West-ward Pharmaceutical Corp. 0641-6065 0641-6065-10 10 VIAL in 1 CARTON (0641-6065-10) > 10 mL in 1 VIAL (0641-6065-01)
MILRINONE LACTATE milrinone lactate INJECTABLE;INJECTION 075530 ANDA West-ward Pharmaceutical Corp. 0641-6067 0641-6067-10 10 VIAL in 1 CARTON (0641-6067-10) > 20 mL in 1 VIAL (0641-6067-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 1MG BASE/ML
Approval Date:May 28, 2002TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Baxter
Daiichi Sankyo
US Department of Justice
Deloitte
Citi
Merck
Mallinckrodt
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot